Status of Anaplastic Lymphoma Kinase (ALK) in Malignant Mesothelioma

被引：0
作者：
Varesano, Serena [1 ]
Leo, Claudio [1 ]
Boccardo, Simona [1 ]
Salvi, Sandra [1 ]
Truini, Mauro [1 ]
Ferro, Paola [3 ]
Fedeli, Franco [3 ]
Canessa, Pier Aldo [4 ]
Dessanti, Paolo [3 ]
Pistillo, Maria Pia [2 ]
Roncella, Silvio [3 ]
机构：
[1] Natl Inst Canc Res, Div Histopathol & Cytopathol, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[2] Natl Inst Canc Res, Unit Tumor Epigenet, Ist Ricovero & Cura Carattere Sci Azienda Osped U, Genoa, Italy
[3] Azienda Sanit Locale 5, Div Histopathol & Cytopathol, La Spezia, Italy
[4] Azienda Sanit Locale 5, Div Pneumol, La Spezia, Italy
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 05期
关键词：
Anaplastic lymphoma kinase; crizotinib; fluorescent in situ hybridization; immunohistochemistry; malignant mesothelioma; targeted therapy; CELL LUNG-CANCER;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Background: Malignant mesothelioma (MM) is a particularly aggressive type of primary tumor, associated with exposure to asbestos, and characterized by high mortality. To date, there is no curative therapy for MM. The receptor anaplastic lymphoma kinase (ALK) was found to be mutated in many cases of cancer and used as a target in biological therapies. We investigated whether this pharmacological treatment could also be applicable to MM. Materials and Methods: The state of ALK was analyzed by immunohistochemistry and fluorescent in situ hybridization in 63 MM tissue specimens. Results: None of the 63 MM samples showed overexpression or translocation of ALK. Conclusion: Our preliminary data exclude the utility of analysis of the ALK gene in MM and suggest that ALK inhibitor therapy is not applicable to MM.
引用
收藏
页码：2589 / 2592
页数：4
相关论文
共 14 条
[1]  
[Anonymous], HIGHL PRESCR INF
[2]   Evaluation of Soluble Mesothelin-related Peptide as a Diagnostic Marker of Malignant Pleural Mesothelioma Effusions: Its Contribution to Cytology [J].
Canessa, Pier Aldo ;
Franceschini, Maria Cristiana ;
Ferro, Paola ;
Battolla, Enrico ;
Dessanti, Paolo ;
Manta, Carmen ;
Sivori, Massimiliano ;
Pezzi, Riccardo ;
Fontana, Vincenzo ;
Fedeli, Franco ;
Pistillo, Maria Pia ;
Roncella, Silvio .
CANCER INVESTIGATION, 2013, 31 (01) :48-55
[3]  
INAIL, 2012, 4 INAIL RENAM
[4]  
Ismail-Khan Roohi, 2006, Cancer Control, V13, P255
[5]   Anaplastic Lymphoma Kinase Inhibition in Non-Small-Cell Lung Cancer [J].
Kwak, Eunice L. ;
Bang, Yung-Jue ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Solomon, Benjamin ;
Maki, Robert G. ;
Ou, Sai-Hong I. ;
Dezube, Bruce J. ;
Jaenne, Pasi A. ;
Costa, Daniel B. ;
Varella-Garcia, Marileila ;
Kim, Woo-Ho ;
Lynch, Thomas J. ;
Fidias, Panos ;
Stubbs, Hannah ;
Engelman, Jeffrey A. ;
Sequist, Lecia V. ;
Tan, WeiWei ;
Gandhi, Leena ;
Mino-Kenudson, Mari ;
Wei, Greg C. ;
Shreeve, S. Martin ;
Ratain, Mark J. ;
Settleman, Jeffrey ;
Christensen, James G. ;
Haber, Daniel A. ;
Wilner, Keith ;
Salgia, Ravi ;
Shapiro, Geoffrey I. ;
Clark, Jeffrey W. ;
Iafrate, A. John .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1693-1703
[6]   Non-solid oncogenes in solid tumors: EML4-ALK fusion genes in lung cancer [J].
Mano, Hiroyuki .
CANCER SCIENCE, 2008, 99 (12) :2349-2355
[7]  
Mendez Miriam, 2011, J Thorac Dis, V3, P30, DOI 10.3978/j.issn.2072-1439.2010.12.03
[8]   A screening method for the ALK fusion gene in NSCLC [J].
Murakami, Yoshiko ;
Mitsudomi, Tetsuya ;
Yatabe, Yasushi .
FRONTIERS IN ONCOLOGY, 2012, 2
[9]   Screening of Anaplastic Lymphoma Kinase Rearrangement by Immunohistochemistry in Non-small Cell Lung Cancer Correlation with Fluorescence In Situ Hybridization [J].
Paik, Jin Ho ;
Choe, Gheeyoung ;
Kim, Hyojin ;
Choe, Ji-Young ;
Lee, Hyun Ju ;
Lee, Choon-Taek ;
Lee, Jong Seok ;
Jheon, Sanghoon ;
Chung, Jin-Haeng .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) :466-472
[10]   The European mesothelioma epidemic [J].
Peto, J ;
Decarli, A ;
La Vecchia, C ;
Levis, F ;
Negri, E .
BRITISH JOURNAL OF CANCER, 1999, 79 (3-4) :666-672
12